All patients underwent decompressivecraniectomy within a maximum period of 48 hours and their characteristics such as age, gender, localization of infarct, hemiplegia,monoplegia, operation time, Glasgow coma and outcome scales were recorded.Results: According to the Glasgow Outcome Scale, 1 patient in Group 1, 8 patients in Group 2 and 6 patients in Group 3 died and therewas a signifiant increase in patient losses in Group 2 and Group 3 compared to Group 1 (p
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Aim: The present study aims to investigate the effects of seizure or epilepsy formation on mortality and morbidity in epilepticpatients after craniectomy.Material and Methods: The patients were divided into the following groups: Group 1, those who had no seizures, but were routinelytreated with 3x100 mg of epanutin daily (n=6), Group 2, those who had at least one or multiple seizures and were initiated a secondantiepileptic drug in addition to 3x100 mg of epanutin daily (n=13), and Group 3, those who had multiple seizures and who weresedated or narcotized in addition to being treated with 3x100 mg of epanutin daily (n=7).
📊
Key Findings & Data:Aim: The present study aims to investigate the effects of seizure or epilepsy formation on mortality and morbidity in epilepticpatients after craniectomy.Material and Methods: The patients were divided into the following groups: Group 1, those who had no seizures, but were routinelytreated with 3x100 mg of epanutin daily (n=6), Group 2, those who had at least one or multiple seizures and were initiated a secondantiepileptic drug in addition to 3x100 mg of epanutin daily (n=13), and Group 3, those who had multiple seizures and who weresedated or narcotized in addition to being treated with 3x100 mg of epanutin daily (n=7).
💡
Conclusion & Impact:All patients underwent decompressivecraniectomy within a maximum period of 48 hours and their characteristics such as age, gender, localization of infarct, hemiplegia,monoplegia, operation time, Glasgow coma and outcome scales were recorded.Results: According to the Glasgow Outcome Scale, 1 patient in Group 1, 8 patients in Group 2 and 6 patients in Group 3 died and therewas a signifiant increase in patient losses in Group 2 and Group 3 compared to Group 1 (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
Aim: The present study aims to investigate the effects of seizure or epilepsy formation on mortality and morbidity in epilepticpatients after craniectomy.Material and Methods: The patients were divided into the following groups: Group 1, those who had no seizures, but were routinelytreated with 3x100 mg of epanutin daily (n=6), Group 2, those who had at least one or multiple seizures and were initiated a secondantiepileptic drug in addition to 3x100 mg of epanutin daily (n=13), and Group 3, those who had multiple seizures and who weresedated or narcotized in addition to being treated with 3x100 mg of epanutin daily (n=7). All patients underwent decompressivecraniectomy within a maximum period of 48 hours and their characteristics such as age, gender, localization of infarct, hemiplegia,monoplegia, operation time, Glasgow coma and outcome scales were recorded.Results: According to the Glasgow Outcome Scale, 1 patient in Group 1, 8 patients in Group 2 and 6 patients in Group 3 died and therewas a signifiant increase in patient losses in Group 2 and Group 3 compared to Group 1 (p
🔖
Cite This Article
GEZGİN, İ., ÇAKIR, T., YÜCETAŞ, S. C., KAFADAR, H. (2022). Effects of epilepsy control following decompressive craniectomy on mortality and morbidity in epileptic patients with malignant MCA infarction. Annals of Medical Research, Cilt: 27 - Sayı: 7, 1982–1988. https://ajindex.com/articles/446333
Brodie MJ, Elder AT, Kwan P. Epilepsy in later life. Lancet Neurol 2009;8:1019-30
Lamy C, Domigo V, Semah F, et al. Patent Foramen Ovale and Atrial Septal Aneurysm Study Group. Early and late seizures after cryptogenic ischemic stroke in young adults. Neurology 2003;60:400-4
Yuan R, Wu S, Cheng Y, et al. Association between preoperative midline shift growing rate and outcomes of decompressive craniectomy in patients with malignant middle cerebral artery infarction. Curr Neurovasc Res 2020;17:25-32
Tuncer N, Elmacı I, Afsar N, et al. Akut iskemik inmede Dekompresif Cerrahi Uygulaması. Sinir Sistemi Cerrahisi Derg 2008;1:20-5
Santamarina E, Sueiras M, Toledo M, et al. Epilepsy in patients with malignant middle cerebral artery infarcts and decompressive craniectomies. Epilepsy Res 2015;112:130-6
Yilmaz C, Ozger O, Kabatas S, et al. The preventive effect of mexiletine on cerebral ischemic injury following experimental middle cerebral artery occlusion. Neurosurg 2009;19:367-73
Bongiorni GT, Hockmuller MCJ, Klein C, et al. Decompressive craniotomy for the treatment of malignant infarction of the middle cerebralartery: mortality and outcome. Arq Neuropsiquiatr 2017;75:424-8
Honeybul S, Ho KM. Long-term complications of decom-pressive craniectomy for head injury. J Neurotrauma 2011;28:929-35
Creutzfeldt CJ, Tirschwell DL, Kim LJ, et al. Seizures after decompressive hemicraniectomy for ischaemic stroke. J Neurol Neurosurg Psychiatry 2014;85:721-5
Landreneau MM, Sheth KN. Decompressive Craniectomy for Malignant Middle Cerebral Artery Stroke. Semin Respir Crit Care Med 2017;38:737-44
Nasi D, Dobran M, Di Rienzo A, et al. Decompressive Craniectomy for Traumatic Brain Injury: The Role of Cranioplasty and Hydrocephalus on Outcome. World Neurosurg 2018;116:543-9
Goedemans T, Verbaan D, Coert BA, et al. Outcome After Decompressive Craniectomy for Middle Cerebral Artery Infarction: Timing of the Intervention. Neurosurgery 2020;86:318-25
Bansal H, Chaudhary A, Singh A, et al. Decompressive craniectomy in malignant middle cerebral artery infarct: An institutional experience. Asian J Neurosurg 2015;10:203-6
Ramakrishnan V, Dahlin R, Hariri O, et al. Anti-epileptic prophylaxis in traumatic brain injury: A retrospective analysis of patients undergoing craniotomy versus decompressive craniectomy. Surg Neurol Int 2015;20:6-8
Taylor B, Lopresti M, Appelboom G, et al. Hemicraniectomy for malignant middle cerebral arte